Many anti-obesity drugs on hot market competition.

Published: 2007-07-27 06:59:00

Updated: 2007-07-27 06:59:00

A serial market launching of local generic drugs for anti-obesity therapy such as Slimmer and NVU raised a hot market competition, and the market success of which seems to be largely depended on its ex-manufacturers prices.

According to the related industrial source, the price of Reductil (Abb...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK